GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » IMAC Holdings Inc (OTCPK:BACK) » Definitions » Cash And Cash Equivalents

BACK (IMAC Holdings) Cash And Cash Equivalents : $0.50 Mil (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is IMAC Holdings Cash And Cash Equivalents?

IMAC Holdings's quarterly cash and cash equivalents declined from Jun. 2024 ($0.89 Mil) to Sep. 2024 ($0.20 Mil) but then increased from Sep. 2024 ($0.20 Mil) to Dec. 2024 ($0.50 Mil).

IMAC Holdings's annual cash and cash equivalents declined from Dec. 2022 ($0.76 Mil) to Dec. 2023 ($0.22 Mil) but then increased from Dec. 2023 ($0.22 Mil) to Dec. 2024 ($0.50 Mil).


IMAC Holdings Cash And Cash Equivalents Historical Data

The historical data trend for IMAC Holdings's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IMAC Holdings Cash And Cash Equivalents Chart

IMAC Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash And Cash Equivalents
Get a 7-Day Free Trial Premium Member Only 2.62 7.12 0.76 0.22 0.50

IMAC Holdings Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cash And Cash Equivalents Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.22 0.02 0.89 0.20 0.50

IMAC Holdings Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.


IMAC Holdings  (OTCPK:BACK) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.


IMAC Holdings Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of IMAC Holdings's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.


IMAC Holdings Business Description

Traded in Other Exchanges
N/A
Address
3401 Mallory Lane, Suite 100, Franklin, TN, USA, 37067
IMAC Holdings Inc is a provider and manager of value-based, conservative medical care combining life science advancements with traditional medical care for movement-restricting diseases and conditions in IMAC Regeneration Centers and BackSpace clinics. Its Innovative Medical Advancements and Care (IMAC) Regeneration Centers combine medical and physical procedures to improve patient experiences and outcomes and reduce healthcare costs as compared to other available treatment options.
Executives
Benjamin S Lerner officer: Chief Operating Officer C/O IMAC HOLDINGS, INC., 1605 WESTGATE CIRCLE, BRENTWOOD TN 37027
Matthew C Wallis director, 10 percent owner, officer: Chief Operating Officer C/O IMAC HOLDINGS, INC., 1605 WESTGATE CIRCLE, BRENTWOOD TN 37027
Michael D Pruitt director 11220 ELM LANE, SUITE 203, CHARLOTTE NC 28277
Cary Sucoff director 1612 EAST CAPE CORAL PKWY, C/O LEGACY EDUCATION ALLIANCE, INC., CAPE CORAL FL 33904
Maurice E. Evans director C/O IMAC HOLDINGS, INC., 1605 WESTGATE CIRCLE, BRENTWOOD TN 37027
Jeffrey S Ervin director, officer: Chief Executive Officer C/O IMAC HOLDINGS, INC., 1605 WESTGATE CIRCLE, BRENTWOOD TN 37027
Hayden Gerard M Jr director C/O PRIVATE BUSINESS INC, P O BOX 1603, BRENTWOOD TN 37024
David Ellwanger director C/O IMAC HOLDINGS, INC., 1605 WESTGATE CIRCLE, BRENTWOOD TN 37027
Sheri Gardzina officer: Interim CFO C/O IMAC HOLDINGS, INC., 1605 WESTGATE CIRCLE, BRENTWOOD TN 37027
George P Hampton director C/O HORIZON PHARMA PLC, 520 LAKE COOK ROAD, STE 520, DEERFIELD IL 60015
Dean Weiland director C/O IMAC HOLDINGS, INC., 1605 WESTGATE CIRCLE, BRENTWOOD TN 37027
Dwight Anthony Bond officer: Chief Financial Officer C/O IMAC HOLDINGS, INC., BRENTWOOD TN 37027